miRNA | Expression pattern | Study model | Sample type | Malignant behavior | Target(s) | Ref. |
---|---|---|---|---|---|---|
miR-21 | Upregulated | In vitro In vivo | U87 glioma cell lines Xenograft tumor | Inhibition of apoptosis | Destabilizing TNFRs and decreasing the molecules involved in apoptosis including caspase-3, caspase-9, and APAF1 | [93] |
miR-221/222 | Upregulated | In vitro In vivo | U251 glioblastoma/rat C6 glioma cells Xenograft tumor model (U251 glioma) | Induce proliferation of cell and disrupt cell death | Cell cycle inhibitors including p27 and/or p57 | [96] |
miR-34a | Downregulated | In vitro | MSCs-U87 U87-MG glioblastoma | Inhibition of glioma cell growth and cell cycle progression | Direct inhibition of expression of various cellular factors such as c-MET RTK, Notch-1, Notch-2, CDK6, CCND1, and SIRT1 | |
miR-124-3p | Downregulated | Human In vitro | Tissue samples U251 and U87 glioma cell lines/SHG44 glioblastoma cell line | Disrupt glioma cell proliferation, invasion, and migration | Connection with a variety of extracellular receptors such as NRP-1 | |
miR-125b | Upregulated | In vitro | U343 and U251 glioma cells | Induction of glioma cell proliferation, as well as inhibiting ATRA-induced cell apoptosis | Interaction with the 3′-UTR of Bmf | [108] |
miR-9 | Downregulated | Human In vitro | Tissue samples U87 MG (CL-0238) and TG-905 (CL-0309) glioblastoma cell lines | Inhibition of glioma cells proliferation and increased apoptosis | FOXG1 signaling | [122] |
miR-186 | Downregulated | Human In vitro | Tissue samples U87 glioma/astrocyte HA1800 cell lines | Increasing apoptosis | Inhibition of Smad6 | [123] |
miR-142-3p | Downregulated | Human In vitro | Tissue samples U251 and U87 cell lines | Inhibition of glioma cells proliferation and mitigates apoptosis | Inactivated Wnt/β-catenin signaling and activated caspase-3 signaling by targeting HMGB1 | [124] |
miR-25 | Upregulated | Human In vitro | Tissue samples U-373MG Uppsala, U-87MG Uppsala, U251MG, and T98G glioma cell lines | Induction of tumor cell migration, invasiveness, and proliferation | Increasing expression of CADM2 | [133] |
miR-146b-5p | Downregulated | Human In vitro | Tissue samples U87MG/SNB19 cell lines | Inhibition of glioma cells migration and invasion | Degradation of MMP16-related mRNA | [139] |
miR-379-5p | Downregulated | In vitro | U87 and U251 glioma cell lines/human astrocyte normal cells/HEB cells | Inhibition of glioma cells viability, migration, invasion, and EMT | Modulation of MGST1 | [140] |
miR-665 | Downregulated | Human In vitro | Tissue samples U251MG, A172, LN18, and T98G glioma cell lines | Inhibition of glioma cell proliferation, migration, and invasion | Targeting HMGB1, as well as inhibiting the Wnt/β-catenin pathway | [143] |
miR-3175 miR-134 | Upregulated Downregulated | Human In vitro | Tissue samples U251 glioma cells | Affecting cell proliferation and apoptosis, as well as EMT | PI3K/Akt pathway | |
miR-296 | Downregulated | Human In vitro | Tissue samples U251 glioma cell line | Inhibition of cell invasion and multidrug resistance | Particular types of potassium channels such as EAG1 (also called KCNH1) | [150] |
miR-320a | Downregulated | Human In vitro | Tissue samples U87 and U251 human glioma cell lines | Impeding invasion and migration of glioma cells | Aquaporin 4 | [151] |
miR-125b | Downregulated | Human In vitro | Pediatric low-grade glioma-derived cell lines (Res186, Res259, and BT66) | A decrease in cell growth and induction of apoptosis | The mechanisms is not clear | [155] |
miR-125b | Downregulated | In vitro | Human brain microvascular endothelial cells | Inhibition of tumor angiogenesis | Molecular loop, which interacts with MAZ, VEGF, and miR-125b | [155] |
miR-210-3P | Upregulated | In vitro | U87-MG, A172, and HS683 glioma cell lines | Induction of invasiveness and EMT in glioma cells Probable involvement in regulation of mitochondrial function | Modification of the mitochondrial membrane potential to improve mitochondrial function | [102] |
miR-93 | Upregulated | Human | Tissue samples | Induction of proliferation, cell cycle progression, colony formation, migration, invasion, and chemoresistance in glioma cells | Integrin β8 | [158] |
miR-124-3p | Downregulated | Human In vitro | Tissue samples U87MG and U251MG cell lines | Inhibition of the proliferation, invasion, and migration of glioma cells | Activating the PI3K/Akt/NF-κB signaling pathway | [152] |
miR-21 | Upregulated | In vitro | U87MG glioma cell line | Inhibition of TMZ-induced apoptosis | Decreasing the Bax/Bcl-2 ratio and caspase-3 activity | [167] |
miR-125b-2 | Upregulated | Human In vitro | Primary culture of glioblastoma tissues-derived cells | Induction of resistance of human glioblastoma stem cells to TMZ | Mitochondrial pathway of apoptosis | [169] |
miR-128 and miR-149 | Downregulated | Human In vitro | Tissue samples U251 and U87 glioma cell line | Inhibition of invasion of glioblastoma cells Increasing the TMZ sensitivity of glioblastoma cells | Rap1B-mediated cytoskeletal and related molecular alterations | [171] |
miR-181a/b/c/d | Downregulated | Human In vitro | Tissue samples U251 and U87 glioma cell line | Increasing the TMZ sensitivity of glioblastoma cells Inhibition of invasive proliferation of glioblastoma cells | Rap1B-mediated cytoskeleton remodeling and related molecular (Cdc42, RhoA, and N-cadherin) changes | [172] |
miR-155-3p | Upregulated | Human In vitro In vivo | Tissue samples LN299, A172, T98, U87, and U251 glioma cell lines and healthy human astrocytes Xenograft mice model (U87) | Induction of cell growth, while its inhibition promotes TMZ sensitivity Induction of cell arrest at the same point that TMZ acts on G1/S phase | Upmodulation of Six1 at translational level | [175] |
miR-141-3p | Upregulated | Human In vitro In vivo | Tissue samples A172, U87, U251, T98, and LN229 glioma cell lines Xenograft mice model (U87) | Induction of cell growth and drug resistance Induction of tumor growth, as well as inhibition of cell apoptosis and cell cycle arrest | Suppression of p53 and its downstream proteins such as CDK2 and cyclin E1/B1, thus inhibiting cell cycle arrest at G1 to S phases | [176] |
miR-195 | Downregulated | In vitro | U251MG glioma cell line | Inhibition of miR-195-induced TMZ resistance and suppression of cell apoptosis of glioma cells | CCNE1 | [177] |
miR-524-5p miR-324-5p | Downregulated | Human In vitro In vivo | Profiling upon 158 glioma samples U87 and U251 glioma cells Xenograft mice model (U87) | Upregulation of miR-524-5p and miR-324-5p reduces glioma cell proliferation, but increases TMZ sensitivity | EZH2 | [180] |
miR-137 | Downregulated | Human | Tissue samples | Inhibition of GSC self-renewal, while promoting their differentiation | Targeting RTVP-1, which downregulates CXCR4 | [188] |
miR-26a | Upregulated | In vitro In vivo | U251, U87, A172, and SHG44 glioma cell lines, human cervical cancer cell line HeLa, human embryonic kidney 293 and 293 T cells Xenograft mice model (U87) | Decreasing AP-2α expression by binding to the 3′-UTR of AP-2α and reversed the tumor-suppressive role of AP-2α in glioma | AP-2α/Nanog signaling axis | [192] |
miR-30a | Downregulated | Human In vitro In vivo | Tissue samples A172, U87, and U251 glioma cell lines Xenograft mice model | Suppression of self-renewal and tumorigenicity of GSCs Exerting some antitumor effects on GSCs | Blocking the NT5E-dependent Akt signaling pathway | [194] |
miR-30c | – | In vitro | Rat C6 glioma cell line | C6 cell sphere formation and neural differentiation to astrocytes | JAK–STAT signaling pathway | [195] |
miR-33a | Upregulated | Human In vivo | Tissue samples Xenograft mice model | Increasing the PDE8A and UVRAG mRNAs’ expression | Modulation of PKA and Notch endocytosis signaling pathways | [196] |
miR-300 | Upregulated | Human In vivo | Tissue samples Xenograft mice model | Increasing the cell proliferation and self-renewal-related activities in patient-derived GSCs | Direct suppression of LZTS2 | [239] |
miR-29a | Downregulated | Human In vitro In vivo | Tissue samples U87 and U251 glioma cell lines BALB/c nude mice | Suppression of proliferation, migration, and invasion, but promotion of glioma cell apoptosis | Aberrated expression of MDM2/4 and final deregulation of the activity of the p53-miR-29a-MDM2/4 feedback loop | [173] |